PRKCA and hepatocellular carcinoma: E2F1 transactivates IQGAP3, and IQGAP3 competitively inhibits the interaction between PKCδ and PKCα, resulting in phosphorylation and activation of PKCα and promotion of cell proliferation in HCC cells [29].